Many Golgi glycosyltransferases are type II membrane proteins which are cleaved to produce soluble forms that are released from cells. Cho and Cummings recently reported that a soluble form of α1,3-galactosyltransferase was comparable to its membrane bound counterpart in its ability to galactosylate newly synthesized glycoproteins (Cho,S.K. and Cummings,R.D. (1997) J. Biol. Chem., 272, 13622-13628). To test the generality of their findings, we compared the activities of the full length and soluble forms of two such glycosyltransferases, ß1,4 N-Acetylgalactosaminyltransferase (GM2/GD2/ GA2 synthase; GalNAcT) and beta galactoside α2,6 sialyltransferase (α2,6-ST; ST6Gal I), for production of their glycoconjugate products in vivo. Unlike the full length form of GalNAcT which produced ganglioside GM2 in transfected cells, soluble GalNAcT did not produce detectable GM2 in vivo even though it possessed in vitro GalNAcT activity comparable to that of full length GalNAcT. When compared with cells expressing full length α2,6-ST, cells expressing a soluble form of α2,6-ST contained 3-fold higher α2,6-ST mRNA levels and secreted 7-fold greater α2,6-ST activity as measured in vitro, but in striking contrast contained 2-to 4-fold less of the α2,6-linked sialic acid moiety in cellular glycoproteins in vivo. In summary these results suggest that unlike α1,3-galactosyltransferase the soluble forms of these two glycosyltransferases are less efficient at glycosylation of membrane proteins and lipids in vivo than their membrane bound counterparts.
Introduction
The glycosyltransferases responsible for the synthesis of glycoprotein and glycosphingolipid (GSL) sugar chains are resident membrane proteins of the endoplasmic reticulum (ER) and Golgi apparatus. Many of these enzymes are type II proteins containing an amino-terminal cytoplasmic region, a transmembrane domain, an extended, flexible stem or stalk region, and a large catalytic domain at the carboxy-terminus . Soluble forms of several endogenously expressed glycosyltransferases have been found in serum, milk, saliva, vitreous humor, and other body fluids Serafini-Cessi et al., 1995; DeBose-Boyd et al., 1996; Allende et al., 1997) as well as in the supernatant from cultured cells (Cho et al., 1996) . In addition, most cloned glycosyltransferases have been reported to be released into the culture medium from transfected cells (Larsen et al., 1989; Kukowska Latallo et al., 1990; Nara et al., 1994; Smith and Lowe, 1994) . Exceptions to this pattern are the blood group H α1,2-fucosyltransferase and UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase (Homa et al., 1993) that are not released when transfected into COS-1 cells and Sf9 insect cells, respectively. In all cases examined to date proteolytic cleavage of the stem portion of membrane bound glycosyltransferases has been found to be responsible for generation of their soluble forms (Jaskiewicz et al., 1996a, and references therein; Cho and Cummings, 1997) .
The biological significance of soluble glycosyltransferases remains to be determined. Extracellularly these soluble enzymes would be unable to complete their sugar transfer reactions due to the lack of sugar nucleotide donors in the extracellular space. Nevertheless, soluble glycosyltransferases could function as lectins by binding to cell surface carbohydrate moieties. In fact Yuan et al., recently proposed that the secreted Fringe-like signaling molecules found in Drosophila might be glycosyltransferases based on sequence homology (Yuan et al., 1997) . Alternatively, soluble glycosyltransferases might function intracellularly prior to being secreted. Investigators have frequently fused the putative catalytic domain of a predicted glycosyltransferase to a secretion signal in order to demonstrate that it actually possessed the expected catalytic activity, rather than being a regulator of glycosyltransferase activity (reviewed in Fukuda et al., 1996) . In each case, the soluble form was found to possess enzymatic activity in vitro, but only two of these reports tested whether these soluble enzymes exhibited significant catalytic capability in vivo. In the case of α1,3-galactosyltransferase (α1,3-GalT), Cho and Cummings reported that the soluble form of this enzyme was highly efficient and comparable to its full length counterpart in α-galactosylating both newly synthesized membranebound and secreted glycoproteins (Cho and Cummings, 1997) . On the other hand, Yamashiro et al., reported that transient transfection with a soluble Protein A/GalNAcT (GM2/GA2/GD2 synthase) fusion protein produced no cell surface expression of GM2 (GalNAcß1,4(NeuAcα2,3)Galß1,4GlcCer) product (Yamashiro et al., 1995) . In the latter case, however, it was possible that GM2 product was not detectable either because the overall level of expression was too low in the transient transfection or because the Protein A portion hindered catalysis in vivo.
In the present study, we used CHO cells stably expressing full length and soluble forms of GalNAcT with and without Protein A to further compare the in vivo activities of these enzyme forms. Here we confirm and extend the finding of Yamashiro et al. (Yamashiro et al., 1995) and conclude that GalNAcT must be membrane bound for efficient GSL synthesis in vivo. In addition we tested the ability of a soluble form of beta galactoside α2,6 sialyltransferase (α2,6-ST) to sialylate glycoproteins and found that it was significantly less efficient in vivo than full length α2,6-ST, indicating that the relative inefficiency of soluble glycosyltransferases is not restricted to enzymes specific for GSL substrates.
Results

Construction of full-length and soluble chimeras of GalNAcT and α2,6-ST
To test the in vivo activity of soluble forms of GalNAcT and α2,6-ST, fusion proteins were constructed as described under Materials and methods and illustrated in Figure 1 . Two full length forms of chimeric GalNAcT, designated GalNAcT/myc and GalNAcT/myc/6His, were constructed as previously described by fusing either the myc epitope tag (Jaskiewicz et al., 1996b) or myc followed by a six histidine sequence (Jaskiewicz et al., 1996a) , respectively, to the C-terminal end of GalNAcT. One soluble form of GalNAcT/myc was constructed by fusion of its luminal domain to the IgG binding domain of protein A as previously described (Jaskiewicz et al., 1996a) . The other soluble constructs, designated sp/GalNAcT/myc and sp-ST (Colley et al., 1992) , were prepared by fusing the cleavable signal peptide of dog pancreatic insulin to the luminal domain of GalNAcT/myc and α2,6-ST, respectively.
The cDNAs were stably transfected into CHO cells by electroporation. Stably expressing cell mixtures and clones were isolated as described in Materials and methods. All cells transfected with GalNAcT constructs contained GalNAcT activity when assayed in vitro (Table I) . As we previously reported for GalNAcT/myc clone C5, GalNAcT/myc/6His clone R8, and Protein A/GalNAcT/myc clone PM6 (Jaskiewicz et al., 1996a) , a high percentage of the total GalNAcT activity in each case was present in the medium. In the case of clone C5 cells, we have shown that this activity in the medium was the result of proteolytic cleavage which released the luminal domain as a soluble species (Jaskiewicz et al., 1996a) .
Cell surface expression of GalNAcT products
We tested the stably expressing cell lines by flow cytometry for their cell surface expression of the GSL GM2 and GA2 (GalNAcß1,4Galß1,4GlcCer). As we reported previously (Jaskiewicz et al., 1996b) , parental CHO cells are negative for both GM2 and GA2 (data not shown). Clone C5 cells expressing full length GalNAcT/myc stained brightly with anti-GM2 (Figure 2 ) as we previously reported (Jaskiewicz et al., 1996b) while staining with anti-GA2 ranged from negative to strong positive (Figure 2 ). We also tested clone R8 cells expressing the full length GalNAcT/ myc/6His protein. Clone R8 cells stained positive with anti-GM2, although not as strongly as clone C5, and negative with anti-GA2 (see Discussion regarding GA2 expression). In striking contrast, clone PM6 cells expressing soluble Protein A/GalNAcT/myc and clone GTm1 cells expressing soluble sp/GalNAcT/myc were negative for both GM2 and GA2. Enzyme activity assays indicated that the lack of GSL cell surface expression in the PM6 and GTm1 cells was not simply due to low GalNAcT activity since the PM6 and R8 cells possessed similar levels of in vitro enzyme activity and the GTm1 cells expressed significantly higher in vitro enzyme activity than either the C5 or R8 cells (Table I ). Together the anti-GM2 flow cytometry results and the in vitro enzyme activity data indicate that expression of GalNAcT in clone R8 cells is sufficient to produce detectable cell surface GM2 but that similar or higher levels of soluble GalNAcT activity of the protein A and signal peptide forms of GalNAcT expressed in clone PM6 or clone GTm1 cells are not able to produce detectable cell surface GM2 expression. These results demonstrate that soluble forms of GalNAcT appear unable to produce detectable cell surface GSL products and that the lack of cell surface GM2 expression on PM6 cells was probably not the result of steric hindrance of GalNAcT activity by the protein A portion of the fusion protein.
In vivo biosynthesis of GalNAcT products
To determine if the flow cytometric results reflected the GSL composition of transfected cells, we labeled cell monolayers with the metabolic precursor [ 3 H]palmitate. As we described previously (Jaskiewicz et al., 1996b) , clone C5 produced as its most complex GSL a strong doublet of GM2 and less intense doublets of GM3 and GA2 ( Figure 3 , lane 1). Clone R8 produced doublets of GM2 and GM3 of equal intensity and only a trace of GA2 ( Figure 3 , lane 6). In contrast to the patterns seen in cells expressing full length GalNAcT, neither PM6 nor GTm1 cells produced detectable GM2 (Figure 3 , lanes 5 and 3, respectively). In both of these cells the only complex GSL was a heavy doublet of GM3. A trace of a doublet comigrating with standard GA2 was detectable in both PM6 and GTm1 (see Discussion regarding GA2 expression), but no trace of GM2 was detectable even after extended exposure to film (data not shown). Clones of stable transfectants were assayed for GalNAc transferase activity using GM3 as substrate as previously described (Jaskiewicz et al., 1996a) . The total activity found in cell extracts prepared from an entire flask (75 cm 2 ) of transfected cells is denoted "cell-associated activity," whereas the total activity found in the processed media harvested from the same flask after 4 days of culture is termed "released activity." One unit of transferase represents the amount of enzyme that can transfer 1 pmol of GalNAc to 15 nmol of GM3 during a 60 min incubation period, after correction for background transfer. % of released activity = [total activity in the conditioned medium ÷ (total cell activity + total medium activity)] × 100. a The data for clones C5, R8, and PM6 were reported previously (Jaskiewicz et al., 1996a) . Fig. 1 . GalNAcT hybrid proteins. Numbers above each construct refer to the amino acid residues of GalNAcT; numbers below to the residues of the sequence fused to GalNAcT; and numbers at the far right to the total length of each construct. GalNAcT/myc: the sequence encoding the 10 amino acid myc epitope recognized by the 9E10 MAb was fused to the carboxyl terminal sequence of GalNAcT. Protein A/GalNAcT/myc: the transin signal peptide and the IgG binding domain of protein A were fused to the luminal domain of GalNAcT/myc. sp/GalNAcT/myc: the signal peptide of dog pancreas insulin was fused to the luminal domain of GalNAcT/myc. α2,6-ST: full-length α2,6-ST. sp-ST: the signal peptide of dog pancreas insulin was fused to the luminal domain of α2,6-ST.
These results suggest that soluble forms of GalNAcT are unable to synthesize GM2 in vivo. A possible explanation for the failure of soluble GalNAcT to produce its GSL products efficiently in vivo was that the soluble enzyme might pass through the Golgi too fast to have enough time to interact with its GSL substrate GM3. Two approaches were taken to extend the time of exposure of soluble GalNAcT to its substrates. First, we attempted to trap both the GSL substrates and soluble GalNAcT in the trans-Golgi network (TGN) by lowering the labeling temperature to 20_C, a condition shown previously to stop protein transport at the level of the TGN and associated vesicles (Matlin and Simons, 1983; Fuller et al., 1985; Griffiths et al., 1985; Musil and Goodenough, 1993) . We had previously localized GalNAcT/myc to all Golgi cisternae as well as the TGN (Jaskiewicz et al., 1996b) . Because synthesis of both LacCer and GM3 was markedly reduced at 20_C (data not shown), the temperature during labeling was cycled between 37_C and 20_C, 1 h at each temperature per cycle, for a total of three cycles. Under these conditions there was a slight increase in labeled LacCer, but the labeling of complex GSL was unchanged from that of cells labeled at 37_C for C5 (data not shown), GTm1 ( Figure 3 , lane 2), or PM6 cells ( Figure 3 , lane 4). Thus, soluble GalNAcT was unable to produce its GSL products efficiently in vivo even under these artificial conditions.
The second approach we used to maximize interaction of soluble GalNAcT with its GSL substrates was the "freeze frame" experiment first described by Sjoberg and Varki (Sjoberg and Varki, 1993) . In this protocol, plasma membranes were perforated under conditions in which the Golgi cisternae were kept intact (Schwaninger et al., 1992) , and N-ethylmaleimide (NEM) was added to prevent intercompartmental vesicular transport. Upon Fig. 2 . Cells expressing full length but not soluble forms of GalNAcT produce detectable cell surface GM2. Cells were incubated with anti-GM2 antibody 10-11 (right panels), anti-GA2 antibody 2D4 (left panels), or control antibody anti-Le Y AH6 (left panels), followed by staining with FITC-conjugated goat anti-mouse Ig. C5, clone C5 expressing GalNAcT/myc; R8, clone R8 expressing GalNAcT/myc/6His; PM6, clone PM6 expressing Protein A/GalNAcT/myc; and GTm1, clone GTm1 expressing sp/GalNAcT/myc. Relative fluorescence is in arbitrary logarithmic units. Profiles for anti-LeY and anti-GA2 staining essentially overlapped for clones R8, PM6, and GTm1.
addition of UDP-[ 3 H]GalNAc, labeled GM2 or GA2 would be produced in any intact Golgi cisterna(e) containing GalNAcT, the UDP-GalNAc transporter, and GM3 or LacCer, respectively. When labeled under these conditions, clone R8 cells produced a doublet of GM2 and a weaker doublet of GA2 ( Figure 4 , lane 2). Thus, in clone R8 cells sufficient GalNAcT colocalized with GM3, LacCer, and the UDP-GalNAc transporter to produce detectable amounts of both GM2 and GA2. Under these freeze frame conditions, clone GTm1 cells produced a GM2 doublet but no detectable GA2 ( Figure 4, lane 4) . Thus, when the soluble form of GalNAcT/myc was trapped in intact Golgi cisternae for the duration of the freeze frame labeling, GM2 was produced. In contrast clone PM6 cells failed to produce either GM2 or GA2 ( Figure 4, lane 3) . In summary the results presented above suggest that the soluble form of an enzyme responsible for GSL synthesis was less efficient than its membrane bound counterpart at in vivo synthesis. To determine whether this inefficiency was restricted to the soluble forms of GSL-specific glycosyltransferases, we next compared the ability of full length and soluble forms of α2,6-ST to sialylate glycoproteins.
In vitro sialyltransferase activity and Northern analysis of α2,6-ST and sp-ST expressing cells
Previous experiments demonstrated that the full length ST tyr form of α2,6-ST is cleaved and secreted from Cos-1 cells (t 1/2 = 6 h), while the soluble sp-ST protein is secreted even more rapidly from both CHO and Cos-1 cells (t 1/2 = 2h) 1992; Ma et al., 1997) . Similarly, we found that a high percentage of sialyltransferase activity was found in the medium of CHO cells stably expressing either the full length ST tyr form of α2,6-ST or the soluble sp-ST protein (Table II ). An earlier report indicated that α2,6-ST was not secreted efficiently from CHO cells . However, the recent finding of two naturally occurring forms of this enzyme, designated the ST tyr and ST cys forms (Ma et al., 1997) , revealed that the ST cys form was used in this earlier study. The ST tyr form was used in the present experiments. For both the stably expressing cell mixtures (ST mix and sp-ST mix) and the single clones (ST clone B5 and sp-ST clone C1), approximately 7-to 8-fold more activity was present in the medium of CHO cells expressing the sp-ST than in the medium of CHO cells expressing the full length α2,6-ST (Table II) . Cells and culture supernatants were assayed for sialyltransferase activity as described in Materials and methods. This assay detected total sialyltransferase activity which included endogenous α2,3 sialyltransferase activity as well as transfected α2,6 sialyltransferase activity. Therefore, the endogenous sialyltransferase activity detected in the conditioned medium from untransfected CHO cells (2533 ± 224 pmol sialic acid/h/plate), which was identical to that of the culture medium alone (α-MEM plus 10% fetal calf serum), was subtracted from the activity detected in the conditioned medium from transfected cells. The values were from a single experiment for the α2,6-ST and sp-ST cell mixtures and were the average of three experiments for the clones. The total activity found in cell extracts from an entire dish (10 cm diameter) is denoted "cell-associated activity," whereas the total activity found in the medium harvested from the same dish after 24 h of culture is termed "released activity." % of released activity = [total activity in the conditioned medium ÷ (total cell activity + total medium activity)] × 100. Northern blot analysis revealed that α2,6-ST mRNA levels of the sp-ST expressing cell mixture were five fold greater than that of the α2,6-ST expressing cell mixture ( Figure 5 , sp-ST Mix and ST Mix). Similarly, sp-ST clone C1 cells expressed 3-fold more sialyltransferase mRNA than full length α2,6-ST clone B5 cells ( Figure 5 , sp-ST clone C1 and ST clone B5). Thus, the ratio of mRNA expression levels was roughly similar to the ratio of in vitro α2,6-ST activities (Table II) . It is possible that the larger difference observed between sp-ST and α2,6-ST in vitro enzyme activities relative to differences in the mRNA levels may reflect a partial inactivation of the full length α2,6-ST enzyme by disulfide-bonded dimerization (Ma et al., 1997) and/or increased turnover.
Surface expression of α2,6-linked sialic acid in α2,6-ST and sp-ST expressing cells
To compare the in vivo activities of full length α2,6-ST and its soluble counterpart, sp-ST, we examined the cell surface expression of glycoconjugates bearing α2,6-linked sialic acid by flow cytometry using FITC-conjugated Sambucus nigra agglutinin (SNA) (Shibuya et al., 1987) . While nontransfected CHO cells exhibited no staining (data not shown), the mixtures of G418 resistant cells that proliferated following transfection contained a proportion of cells that were positive for SNA staining (21% positive for full length α2,6-ST expressing cells and 30% for the soluble sp-ST expressing cells; Figure 6A ). Most significantly, the peak for positive staining of the ST cell mixture (fluorescence channel 46) was almost twice that of the sp-ST cell mixture (channel 24), suggesting increased display of α2,6-linked sialic acid on the cells expressing full length α2,6-ST. Five clones selected from each cell mixture retained this difference in SNA cell surface reactivity as shown for ST clone B5 and sp-ST clone C1 in Figure 6B . The average peak fluorescence channel was 36.8 ± 1.4 for clones expressing full length α2,6-ST and 18.2 ± 2.8 for the five sp-ST clones. Thus, flow cytometry provided evidence that the soluble form of α2,6-ST might not be as efficient as its full length counterpart at producing SNA-reactive cell surface glycoconjugates. However, because flow cytometric results can be influenced by additional factors such as crypticity of reactive epitopes, we tested for sialylation of individual glycoproteins by SNA lectin blotting.
Lectin blot analysis of glycoconjugates in α2,6-ST and sp-ST expressing cells
To investigate whether there were either qualitative or quantitative differences in α2,6-linked sialylation of glycoproteins in cells expressing either full length α2,6-ST or soluble sp-ST, cell extracts were analyzed by SNA lectin blotting. Both types of transfected cells contained multiple species of α2,6-linked sialylated glycoproteins ranging from 70 kDa to 200 kDa, with two intensely labeled sets of bands at ca. 90-110 kDa and 130-145 kDa ( Figure 7A,B) . Specificity of SNA binding was demonstrated by neuraminidase treatment which almost totally obliterated the reactive bands from the cell extract ( Figure 7C ).
Quantitatively the α2,6-linked sialic acid moiety in cellular proteins in the α2,6-ST expressing cell mixture was approximately 4-fold more abundant than in the sp-ST expressing cells as indicated by blotting of serial dilutions (Figure 7) . Similarly, the amount of α2,6-linked sialic acid in cellular proteins of α2,6-ST clone B5 cells was between 2-and 4-fold greater than those in sp-ST clone C1 ( Figure 7B ). No significant qualitative differences in the patterns of SNA-reactive species were apparent that could not be explained by the quantitative difference in labeling. In summary, these lectin blotting results agree with the flow cytometric results (Figure 6 ) and indicate that CHO cells expressing the full length form of α2,6-ST contain higher levels of glycoprotein-bound α2,6-linked sialic acid than cells expressing the soluble form of this sialyltransferase. 
Discussion
In the present study, we have shown that the soluble forms of two Golgi glycosyltransferases glycosylate less efficiently in vivo than their membrane bound counterparts. The soluble forms of GalNAcT failed to produce any detectable ganglioside GM2 in vivo (Figure 3, lanes 2-5) . However, soluble GalNAcT was capable of synthesizing GM2 when tested under freeze frame conditions using clone GTm1 (Figure 4, lane 4) which expressed the luminal domain of GalNAcT/myc. The fact that no detectable GM2 was produced in clone PM6 cells expressing the Protein A/GalNAcT/myc soluble form even under freeze frame conditions may simply have been due to its low activity (Table I) . Unfortunately, clone PM6 was the strongest producer that we were able to isolate with this construct.
Analysis of GA2 production is complicated by several factors. GA2 cell surface expression can be masked by neighboring molecules (Urdal and Hakomori, 1983) ; therefore, a negative GA2 result by flow cytometry does not necessarily mean a total lack of GA2 synthesis or even the absence of GA2 at the cell surface. Furthermore, we and others have shown previously (Lutz et al., 1994; Yamashiro et al., 1995) that synthesis of GA2 by cloned GalNAcT varied with the expression system and cell type. In the present study, only clone C5 produced detectable cell surface GA2 (Figure 2 ) and strong GA2 synthesis upon metabolic labeling (Figure 3) . However, clones PM6 and GTm1 produced traces of apparent GA2 (Figure 3) suggesting that the soluble forms of GalNAcT might be slightly more efficient for producing GA2 than for producing GM2.
Cells expressing sp-ST, the soluble form of α2,6-ST, produced a spectrum of α2,6-sialylated glycoproteins that was qualitatively identical to that seen in cells expressing full length α2,6-ST (Figure 7) . However, the soluble form produced 2-to 4-fold less α2,6-linked sialic acid on cellular proteins than the full length form (Figures 6 and 7) despite the fact that the mRNA level and the in vitro α2,6-ST activity produced by sp-ST expressing cells were at least three fold and seven fold greater, respectively, than that of cells expressing full length α2,6-ST ( Figure 5 , Table II ). Cho and Cummings recently reported that a soluble form of α1,3-GalT was comparable to the full length form of this enzyme in its ability to α-galactosylate both newly synthesized membrane-associated and secreted glycoproteins (Cho and Cummings, 1997 ). We did not analyze secreted glycoproteins in our present study because of the large amount of α2,6-sialylated proteins present in calf serum and in serum free medium (data not shown). However, it has been reported that a soluble form of α2,6-ST did not modify several secretory glycoproteins when they were cotransfected with the soluble transferase into BHK cells (Grabenhorst et al., 1997) In the present study the relative abilities of membrane-bound versus the soluble form of α2,6-ST to sialylate membrane proteins clearly differ from that of the corresponding forms of α1,3-GalT and suggest that the extent to which soluble glycosyltransferases will participate in in vivo glycosylation may vary depending on the enzyme. One cause for such differences could be motifs in the glycosyltransferase luminal domains which could lead to retention of soluble forms, as suggested for α1,3-GalT (Cho and Cummings, 1997) .
In general, however, the kinetics of catalysis by membrane bound enzymes are complex as recently reviewed by Nelsestuen and Martinez (Nelsestuen and Martinez, 1997) , making it impossible to predict the relative activities of soluble versus membrane bound enzyme forms. Nevertheless, several examples have suggested that the distance of glycosylation sites from the membrane can influence reactivity of effector molecules at those sites. First, Fukuda et al., found that membrane bound but not soluble forms of human chorionic gonadotropin-α chain acquired polylactosaminoglycan chains (Fukuda et al., 1988) . Second, Hebert et al. reported that the soluble chaperone calreticulin reacted preferentially with the glycosylation sites on influenza hemagglutinin more distant from the membrane whereas the membrane bound chaperone calnexin reacted with all sites (Hebert et al., 1997) . Finally in this regard, Clausen and Bennett proposed that differences in stem length of members of the UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferase family could influence substrate specificity by varying access of the catalytic domain to substrates in the Golgi lumen (Clausen and Bennett, 1996) . Given these examples, it seems possible that membrane bound forms of glycosyltransferases could act more efficiently than soluble forms to glycosylate membrane bound substrates, particularly those that are closer to the membrane such as GSL.
Many studies have been directed at defining the cis to trans cisternal distribution of Golgi glycosyltransferases as well as the mechanisms responsible for the generation and maintenance of that distribution (Colley, 1997) . In contrast to fairly detailed information on this topic, there is minimal direct data at present concerning the organization of the glycosyltransferases within individual cisternae and the spatial relationships between these enzymes and their substrates. Monica et al. recently proposed a mathematical model of sialylation of the N-linked chains of secreted proteins (Monica et al., 1997) , but no similar analysis has been made for the membrane bound substrates we dealt with in the present study. In the kin recognition hypothesis, Nilsson et al. proposed that resident proteins within each Golgi cisterna would interact with each other and form large hetero-oligomers through their membrane-spanning domains (Nilsson et al., 1993) . Because of their large size, these hetero-oligomers would be prevented from entering transport vesicles destined for the next compartment along the secretary pathway and thus would be retained in that cisterna. Two possibilities regarding glycosyltransferase function arise from the kin recognition model. First, the membrane-bound form of a glycosyltransferase would be one of the components of the large oligomers, therefore immobilized within a highly concentrated protein microenvironment. Thus, the membrane-bound form might not have easy access to certain substrates, whereas the soluble form would be free to diffuse, thus more easily interacting with some substrates within a given cisterna. However, our results in the present study suggest that this is not the case at least for the two enzymes studied here. Second, glycosyltransferases might be arranged in functional multienzyme complexes. In fact based on labeling of rat brain gangliosides in vivo, Caputto et al. proposed that each type of ganglioside was synthesized by its own multienzyme complex (Caputto et al., 1976) . Similarly, Kijimoto-Ochiai et al. proposed that Forssman glycolipid was synthesized by a complex of ß-and α-GalNAc transferases from ceramide trihexoside without the accumulation of the intermediate globoside (Kijimoto-Ochiai et al., 1980) . If these complexes were composed of membrane bound enzymes and if GM2 was synthesized by such a multienzyme complex in CHO cells, then soluble GalNAcT would clearly be at a disadvantage as compared to its full length counterpart with regard to its ability to produce GSL products in vivo.
Combining the present results with those of our previous studies, we can summarize the life histories of these two enzymes as follows. Initially GalNAcT is formed in the ER as a disulfide bonded homodimer (Zhu et al., 1997) which possesses in vitro activity but is unable to produce GSL products in vivo (Jaskiewicz et al., 1996b) . GalNAcT then resides in the Golgi with an intracellular half-time of ∼1.7 h (Jaskiewicz et al., 1996a) and finally is cleaved late in the secretory pathway (Jaskiewicz et al., 1996a) to produce a soluble dimer which we show in the present study to have in vivo activity that is greatly reduced as compared to its full length counterpart. The life cycle for α2,6-ST is more complex. For the ST-tyr form (Ma et al., 1997) used in the present study, a monomeric, fully active form moves from the ER to the Golgi where roughly one-third assembles into an inactive homodimer (Ma and Colley, 1996) . Late in the secretory pathway, the remaining monomer is cleaved (Ma et al., 1997) to a soluble form which we show in the present study to be less active than the membrane bound monomer. Thus, for both enzymes the majority of the glycosylation that occurs in vivo must be the result of the action of the membrane bound form.
Materials and methods
Materials
Tissue culture media, geneticin, proteinase K, and the Rad Prime DNA labeling system were purchased from Life Technologies, Inc., Grand Island, NY. PCR primers were purchased from Genosys, The Woodlands, TX. [9, 
Chimeric constructs
GalNAcT/myc, GalNAcT/myc/6His, Protein A/GalNAcT/myc, and sp-ST constructs have been described elsewhere (Colley et al., 1992; Jaskiewicz et al., 1996a,b) and are summarized in Figure 1 . We should note that the form of α2,6-ST used here was designated the ST tyr form previously (Ma et al., 1997) . In addition the cleavable signal peptide of dog pancreas insulin (Kwok et al., 1983; Halberg et al., 1987) was fused to the luminal domain of GalNAcT/myc to produce sp/GalNAcT/myc as follows. The sp-ST plasmid (Colley et al., 1992) was used as a template in a polymerase chain reaction (PCR) to amplify the cDNA encoding the dog insulin signal peptide sequence. PCR primers were as follows: sense, 5′ ATATAAGCTTGCCACCAC-CATGGCCCTCTGGATGCGCCT; antisense, 5′ TCGAC-CCGGGATCCTCTAGAGTCAAC. The sense primer coded for the first six amino acid residues of the dog insulin signal peptide and contained a HindIII restriction site and a Kozak consensus sequence. The antisense primer was complementary to an eighteen base sequence, which contained XmaI, XbaI, and BamHI sites and was located as a spacer between the cleavable signal peptide and sp-ST coding sequence in the sp-ST plasmid. After double digestion with HindIII and XmaI, the PCR product was subcloned into pCDM8 containing the GalNAcT/myc insert (Jaskiewicz et al., 1996b) , and the chimeric construct was confirmed by DNA sequencing (Macromolecular Structure Analysis Facility, University of Kentucky, Lexington, KY).
Cell culture and transfection
Wild type CHO cells were the gift of J. Baenziger (Washington University) and were grown in α-minimal essential medium containing 10% (v/v) fetal calf serum plus glutamine at 37_C. Cells were transfected and clones selected as described previously (Jaskiewicz et al., 1996a,b) . Transfected cells were maintained in complete medium containing 0.4 mg/ml of active geneticin.
Flow cytometry
Staining of transfected CHO cells with monoclonal anti-GM2 10-11 (Natoli et al., 1986) and anti-GA2 (Young et al., 1979) has been described (Lutz et al., 1994) . Monoclonal anti-Lewis Y AH6 (Abe et al., 1983 ) was a gift from Dr. S. Hakomori. For staining with FITC-SNA, transfected CHO cells were trypsinized and incubated for 30 min at 4 0 C with FITC-SNA diluted 1:100 in PBS-BSA (phosphate buffered saline, pH 7.4, containing 1% BSA). After washing, the cells were resuspended in PBS-BSA and analyzed on an Epics Elite flow cytometer (Coulter, Hialeah, FL).
GalNAcT enzyme assay
The in vitro assay for GalNAcT activity has been described elsewhere (Jaskiewicz et al., 1996b) . Conditioned medium was centrifuged at 250 × g for 10 min at 4_C, and the supernatant was centrifuged at 100,000 × g for 1 h at 4_C to remove any cell debris from the culture medium prior to enzyme analysis. The protein concentration of cell extracts was determined by the BCA method (Smith et al., 1985) (Pierce Chemical Co., Rockford, IL).
Metabolic labeling
Confluent cell monolayers were labeled in medium containing 25 µCi/ml [9,10-3 H]palmitic acid (30 Ci/mmol), and GSL extracted, purified, and analyzed by high performance thin layer chromatography (HPTLC) in solvent A (CHCl 3 :MeOH:0.25% KCl, 50:40:10, v/v) as described previously (Jaskiewicz et al., 1996b) .
Freeze frame experiment
The following modifications of the original protocol (Sjoberg and Varki, 1993) were used. Semi-intact cells were prepared as described previously (Schwaninger et al., 1992) . Briefly, all steps were at 4_C. Cells were washed in perforating buffer (50 mM HEPES, pH 7.2, 90 mM potassium acetate), incubated in swelling buffer (10 mM HEPES, pH 7.2, 18 mM potassium acetate) for 10 min, harvested in perforating buffer with a rubber policeman, and centrifuged at 800 × g for 3 min. The cell pellet was suspended in PB containing 125 µg/ml N-ethylmaleimide, to prevent intercompartmental vesicular transport. Semi-intact cell suspensions were incubated with UDP-[ 3 H]GalNAc at 25_C for 30 min and then subjected to GSL extraction and analysis by HPTLC as described above. The intactness and correct topology of the compartments being labeled were assessed by a protease protection assay (Sjoberg and Varki, 1993) . In all cases >93% of the perchloric acid-precipitatable radioactivity was protected from proteinase K digestion, decreasing to <9% upon addition of Triton X-100 to the cell suspension prior to protease addition.
Lectin blotting
Cell extracts were prepared as described previously (Jaskiewicz et al., 1996b) . After SDS-PAGE on a 4% stacking, 8% separating gel, proteins were transferred to a PVDF membrane (Millipore, Marlborough, MA). Detection of glycosylated proteins using dioxigenin-labeled SNA lectin and the BM chemiluminescence blotting kit was performed according to the manufacturer's instructions. For neuraminidase treatment, cell extracts were incubated in 10 µl of 50 mM sodium acetate buffer pH 4.5 with 1 mU of Vibrio cholerae neuraminidase for 18 h at 37_C prior to lectin blotting.
Sialyltransferase assays
Cells were grown in 100 mm tissue culture dishes, and at ∼75% confluency, the medium was replaced with 4 ml of fresh medium. After 16 hr, the medium was harvested; the cells were washed with PBS, scraped into 1 ml of PBS, and centrifuged; and the cell pellet was resuspended and lysed in 250 µl 10 mM sodium cacodylate, pH 6.5, 0.15 M NaCl, 0.5% Triton CF-54. Following clarification of the cell lysate, 25 µl of both lysate and medium were used in the sialyltransferase assay as described previously Ma and Colley, 1996; Ma et al., 1997 
mRNA preparation and Northern blot analysis
Total RNA was prepared from confluent cells using the RNAzol B reagent according to the procedure provided by the supplier. Mini-Oligotex spin columns were used for preparing poly A+ mRNA according to the manufacturer's instructions. Two hundred fifty micrograms of total RNA was loaded on each column, and the columns were eluted using 20 ml of the elution buffer. Five microliters of purified poly A+ mRNA was fractionated on a 1% formaldehyde-agarose gel (Chruch and Gilbert, 1984) , and then transferred to a nylon membrane (Qiagen) (Chruch and Gilbert, 1984) . A 606 base pair BglII fragment (nucleotides 324-930) of α2,6-ST cDNA and glyceraldehyde 3 phosphate dehydrogenase (GAPDH) full length cDNA were used as templates for generating 32 P-labeled probes using α 32 P-ATP and the RadPrime DNA labeling system. Hybridization was carried out at 42_C according to previously described procedures (Ausubel et al., 1993) , and the blot was washed twice with 1× SSC, 0.1% SDS at room temperature for 20 min, twice with 0.1× SSC, 0.1% SDS at 68_C for 20 min, and then subjected to autoradiography. GA2, GalNAcß1, 4Galß1, 4GlcCer; GalNAcT, ß1 ,4 N-acetylgalactosaminyltransferase (GM2/GD2/GA2 synthase); α1,3 GalT, α1,3-galactosyltransferase; α2,6-ST, ß-galactoside α2,6-sialyltransferase; HPTLC, high performance thin layer chromatography; sp-ST, a soluble form of α2,6-ST; PCR, polymerase chain reaction; and SNA, Sambucus nigra agglutinin.
